Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Wark (Newcastle, Australia), K. Nichol (Newcastle, Australia), D. Dorahy (Newcastle, Australia), A. Collison (Newcastle, Australia), J. Mattes (Newcastle, Australia). Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses.. 534

Member's Comments

No comment yet.

Related content which might interest you: Long-term bortezomib treatment decreases allergen-specific IgE but fails to amend chronic asthma in mice Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012 The profile of dendritic cell and T cell response is related to the viral trigger in children with severe asthma exacerbation Source: Annual Congress 2012 - Immunologic mechanisms in COPD and asthma Year: 2012 Interferon-γ-pretreated dendritic cells induced dual Th1 and Th2 responses and failed to prevent development of allergic airway inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 230s Year: 2006 Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 50s Year: 2005 Improving of experimental allergic asthma by decreased Th2 responses in OGR-1 knockout mice Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009 Impaired TLR7-induced type I interferon responses in asthmatic teenagers, despite normal frequencies of circulating plasmacytoid dendritic cells Source: Annual Congress 2007 - Novel aspects in airway inflammation in human asthma and rhinitis Year: 2007 Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 T-cell co-stimulatory molecules: novel targets for the treatment of allergic airway disease Source: Eur Respir J 2007; 30: 383-390 Year: 2007 Cytokine production profile of T-lymphocytes and frequence of regulatory T-cells in patients with allergic asthma receiving anti-IgE therapy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 Omalizumab enhances the percentage of GARP cells in both regulatory and terminally differentiated effector Th cells in severe allergic asthmatics Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Omalizumab decreases IgE production in patients with severe allergic asthma Source: Annual Congress 2012 - Aspects of clinical asthma Year: 2012 Anticholinergic treatment does not affect toll-like receptor 3-induced antiviral immune response in COPD bronchial epithelial cells Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 The declined CD4+ CD25+Treg cells in patients with moderate to severe asthma associated with over-expressed Th2 response Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012 Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases Year: 2019 Effectiveness of photobiomodulation on the increase of Treg cells and IL-10 cytokine in an experimental model of chronic asthma Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Antigen capture and processing by airway dendritic cells is attenuated in mice following chronic aero-allergen exposure Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab Source: International Congress 2019 – Treatment of asthma with monoclonal antibodies Year: 2019 Pulmonary type-2 innate lymphoid cells in paediatric severe asthma: phenotype and response to steroids Source: Eur Respir J, 54 (2) 1801809; 10.1183/13993003.01809-2018 Year: 2019